Impact of Smoking Status on Disease Severity and Mortality of Hospitalized Patients With COVID-19 Infection: A Systematic Review and Meta-analysis.
作者信息
Karanasos Antonios, Aznaouridis Konstantinos, Latsios George, Synetos Andreas, Plitaria Stella, Tousoulis Dimitrios, Toutouzas Konstantinos
机构信息
First Department of Cardiology, University of Athens, Hippokration Hospital, Athens, Greece.
出版信息
Nicotine Tob Res. 2020 Aug 24;22(9):1657-1659. doi: 10.1093/ntr/ntaa107.
Abstract
摘要
相似文献
1
Impact of Smoking Status on Disease Severity and Mortality of Hospitalized Patients With COVID-19 Infection: A Systematic Review and Meta-analysis.吸烟状况对COVID-19感染住院患者疾病严重程度和死亡率的影响：一项系统评价和荟萃分析。
Nicotine Tob Res. 2020 Aug 24;22(9):1657-1659. doi: 10.1093/ntr/ntaa107.
引用本文的文献
1
The Effect of Health Belief Model-Based Creative Drama Education on Health Locus of Control and Smoking Perception in Adolescents: A Randomized Controlled Trial.基于健康信念模型的创意戏剧教育对青少年健康控制点和吸烟认知的影响：一项随机对照试验。
Public Health Nurs. 2025 May-Jun;42(3):1343-1353. doi: 10.1111/phn.13550. Epub 2025 Mar 6.
2
Tobacco harm perceptions, regulatory attitudes, and cessation intentions before and after the COVID-19 lockdown in California.加利福尼亚州新冠疫情封锁前后的烟草危害认知、监管态度及戒烟意愿
Health Psychol Open. 2024 Dec 2;11:20551029241306095. doi: 10.1177/20551029241306095. eCollection 2024 Jan-Dec.
3
Handgrip strength as a prognostic factor for COVID-19 mortality among older adult patients admitted to the intensive care unit (ICU): a comparison Alpha (B.1.1.7) and Delta (B.1.617.2) variants.握力作为入住重症监护病房（ICU）老年患者 COVID-19 死亡率的预后因素：Alpha（B.1.1.7）和 Delta（B.1.617.2）变异株的比较。
Sci Rep. 2024 Aug 27;14(1):19927. doi: 10.1038/s41598-024-71034-w.
4
Risk Factors for COVID-19 and Respiratory Tract Infections during the Coronavirus Pandemic.新冠疫情期间COVID-19和呼吸道感染的风险因素
Vaccines (Basel). 2024 Mar 19;12(3):329. doi: 10.3390/vaccines12030329.
5
Looking at the Data on Smoking and Post-COVID-19 Syndrome-A Literature Review.审视吸烟与新冠后综合征的数据——文献综述
J Pers Med. 2024 Jan 16;14(1):97. doi: 10.3390/jpm14010097.
6
Association of substance use with outcomes in mildly ill COVID-19 outpatients.物质使用与轻度 COVID-19 门诊患者结局的关联。
Am J Emerg Med. 2023 Dec;74:27-31. doi: 10.1016/j.ajem.2023.09.017. Epub 2023 Sep 20.
7
The predisposition of smokers to COVID-19 infection: A mini-review of global perspectives.吸烟者对新冠病毒感染的易感性：全球视角的小型综述。
Heliyon. 2023 Jun 29;9(7):e17783. doi: 10.1016/j.heliyon.2023.e17783. eCollection 2023 Jul.
8
Changes in lifestyle-related behaviour during the COVID-19 pandemic in Japan: a questionnaire survey for examinees who underwent an annual health check-up.日本 COVID-19 大流行期间与生活方式相关行为的变化：对接受年度健康检查者的问卷调查。
J Int Med Res. 2023 Jul;51(7):3000605231184036. doi: 10.1177/03000605231184036.
9
No difference in COVID-19 treatment outcomes among current methamphetamine, cannabis and alcohol users.目前使用甲基苯丙胺、大麻和酒精的人群在新冠病毒疾病治疗结果上没有差异。
J Cannabis Res. 2023 Jun 19;5(1):23. doi: 10.1186/s42238-023-00193-w.
10
The controversial effect of smoking and nicotine in SARS-CoV-2 infection.吸烟和尼古丁在新冠病毒感染中的争议性影响。
Allergy Asthma Clin Immunol. 2023 Jun 1;19(1):49. doi: 10.1186/s13223-023-00797-0.
本文引用的文献
1
A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications.一种与 COVID-19 相关的烟碱能假说及其预防和治疗意义。
C R Biol. 2020 Jun 5;343(1):33-39. doi: 10.5802/crbiol.8.
2
Risk Factors Associated With Clinical Outcomes in 323 Coronavirus Disease 2019 (COVID-19) Hospitalized Patients in Wuhan, China.中国武汉 323 例新型冠状病毒病（COVID-19）住院患者临床结局的相关危险因素分析。
Clin Infect Dis. 2020 Nov 19;71(16):2089-2098. doi: 10.1093/cid/ciaa539.
3
Clinical and Laboratory Predictors of In-hospital Mortality in Patients With Coronavirus Disease-2019: A Cohort Study in Wuhan, China.临床和实验室预测因子对新型冠状病毒肺炎患者住院死亡率的影响：一项在中国武汉的队列研究。
Clin Infect Dis. 2020 Nov 19;71(16):2079-2088. doi: 10.1093/cid/ciaa538.
4
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.SARS-CoV-2 感染患者外周血淋巴细胞反应和细胞因子谱的纵向特征。
EBioMedicine. 2020 May;55:102763. doi: 10.1016/j.ebiom.2020.102763. Epub 2020 Apr 18.
5
Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China.中国浙江台州 145 例新型冠状病毒病（COVID-19）患者的临床特征。
Infection. 2020 Aug;48(4):543-551. doi: 10.1007/s15010-020-01432-5. Epub 2020 Apr 28.
6
Clinical Characteristics of Covid-19 in New York City.纽约市新冠肺炎的临床特征
N Engl J Med. 2020 Jun 11;382(24):2372-2374. doi: 10.1056/NEJMc2010419. Epub 2020 Apr 17.
7
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.武汉成人 COVID-19 住院患者严重程度和死亡率的危险因素。
J Allergy Clin Immunol. 2020 Jul;146(1):110-118. doi: 10.1016/j.jaci.2020.04.006. Epub 2020 Apr 12.
8
Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China.中国安徽阜阳 125 例 COVID-19 住院患者的流行病学和临床特征。
Int J Infect Dis. 2020 Jun;95:421-428. doi: 10.1016/j.ijid.2020.03.070. Epub 2020 Apr 11.
9
COVID-19 with Different Severities: A Multicenter Study of Clinical Features.不同严重程度的 COVID-19：一项多中心临床特征研究。
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1380-1388. doi: 10.1164/rccm.202002-0445OC.
10
Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score.COVID-19 肺炎患者进展风险预测：CALL 评分。
Clin Infect Dis. 2020 Sep 12;71(6):1393-1399. doi: 10.1093/cid/ciaa414.
Zotero 插件